NIH Center for Scientific Review Announces Closed Meetings
Summary
The National Institutes of Health (NIH) has published a notice announcing several upcoming closed meetings for the Center for Scientific Review. These meetings, scheduled for April 2026, will involve the review and evaluation of grant applications, which may contain confidential commercial or personal information.
What changed
The National Institutes of Health (NIH), through its Center for Scientific Review (CSR), has issued a notice detailing several upcoming closed meetings. These meetings, scheduled for April 16-17 and April 22, 2026, involve review panels for various scientific study sections, including Emerging Technologies and Training Neurosciences, Neuromodulation, Imaging of Neuronal Circuits, Cancer Research, Metabolic-Associated Liver Disease, and others. The meetings are closed to the public under the Federal Advisory Committee Act due to the potential disclosure of confidential trade secrets, patentable material, or personal information.
Compliance officers should note that this is an informational notice regarding the scheduling of these review meetings. No specific actions are required from regulated entities as a result of this notice. The primary implication is for researchers and institutions submitting grant applications that will be reviewed in these closed sessions. The NIH has provided contact information for each specific review panel for further inquiries.
Source document (simplified)
Notice
Center for Scientific Review; Notice of Closed Meetings
A Notice by the National Institutes of Health on 03/27/2026
PDF
Document Details
Document Dates
- Table of Contents
- Public Comments
- Regulations.gov Data
- Sharing
- Other Formats
- Public Inspection Published Document: 2026-05957 (91 FR 14861) Document Headings ###### Department of Health and Human Services
National Institutes of Health
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Emerging Technologies and Training Neurosciences Integrated Review Group; Neuromodulation ( printed page 14862) and Imaging of Neuronal Circuits Study Section.
Date: April 16-17, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Pablo Miguel Blazquez Gamez, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042, pablo.blazquezgamez@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Program Project: Cancer Research.
Date: April 22, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sandhya Sanghi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-2879, sandhya.sanghi@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Metabolic-Associated Liver Disease.
Date: April 22, 2026.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Murali Ganesan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, murali.ganesan@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Research Enhancement Award and SuRE Programs (R15 and R16).
Date: April 22, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Center for Scientific Review (CSR), National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-7987, susan.sunnarborg@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Special: Topics in pathophysiology, imaging, and therapeutic strategies for eye diseases.
Date: April 22, 2026.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-5702, sindhu.kizhakkemadathil@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Special: Respiratory Topics.
Date: April 22, 2026.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Prashant Sharma, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 275-6351, prashant.sharma@nih.gov.
Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Interventions to Prevent and Treat Addictions Study Section.
Date: April 22-23, 2026.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Izabella Zandberg, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0359, izabella.zandberg@nih.gov.
Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Analytics and Statistics for Population Research Panel B Study Section.
Date: April 22-23, 2026.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Tadeu Rebustini, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892, (301) 827-1641, ivan.rebustini@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; T32 Institutional Training Grant Review.
Date: April 22, 2026.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Kan Ma, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-4838, mak2@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Molecular Virology, Pathogenesis, and Vaccine Development.
Date: April 22, 2026.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Joshua D Powell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-5370, josh.powell@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Addiction Risks and Mechanisms.
Date: April 22, 2026.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Li Jia, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-2854, li.jia@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Infectious Diseases.
Date: April 22, 2026.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Dayadevi Jirage, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4422, Bethesda, MD 20892, (301) 867-5309, jiragedb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Training: Immunology and Infectious Diseases C.
Date: April 22, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Susham Shankarrao Ingavale, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 961-1172, susham.ingavale@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
( printed page 14863) Dated: March 24, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-05957 Filed 3-26-26; 8:45 am]
BILLING CODE 4140-01-P
Published Document: 2026-05957 (91 FR 14861)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FR: National Institutes of Health publishes new changes.